Global rates of type2diabetes in children and adolescents have increased significantly
over the past three decades. Type2diabetes is a relatively new disease in this age group, and
there is a dearth of information about how to structure treatment programs to manage its
comorbidities and complications. In this paper, we describe the design and implementation
of a personalized multidisciplinary, family-centered, pediatric and adolescent type2diabetes
program at a tertiary pediatric center in Hamilton, Ontario, Canada. We report the process of
designing and implementing such a program, and show that this multidisciplinary program
led to improvement in glycated hemoglobin (n=17, 8% at baseline versus 6.4% at 1 year, 95%
confidence interval (0.1–0.28), P-value <0.0001) and stabilized body mass index, with lowered
C-peptide and no change in fitness or metabolic biomarkers of lipid metabolism and liver function. As type2diabetes becomes more prevalent in youth, the need for programs that successfully address the complex nature of this disease is central to its management and to mitigate its
long-term adverse outcomes.
การแปล กรุณารอสักครู่..
